Immunotherapy with FBTA05 (Bi20), a trifunctional anti-CD3 x anti-CD20 antibody in recurrent childhood B-cell malignancies

被引：0
|
作者：
Schuster, F. [1 ]
Stanglmaier, M. [2 ]
Woessmann, W. [3 ]
Winkler, B.
Meisel, R. [1 ]
Schlegel, P. G. [4 ]
Lindhofer, H. [2 ]
Reiter, A. [3 ]
Borkhardt, A. [1 ]
Buhmann, R. [5 ]
机构：
[1] Dept Paediat Oncol Haematol & Immunol, Dusseldorf, Germany
[2] TRION Res, Munich, Germany
[3] Univ Giessen, Giessen, Germany
[4] Univ Wurzburg, Wurzburg, Germany
[5] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
  • [1] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H-J
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 383 - 397
  • [2] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 × anti-CD20 antibody and donor lymphocyte infusion
    R Buhmann
    B Simoes
    M Stanglmaier
    T Yang
    M Faltin
    D Bund
    H Lindhofer
    H-J Kolb
    [J]. Bone Marrow Transplantation, 2009, 43 : 383 - 397
  • [3] IMMUNOTHERAPY OF RECURRENT B-CELL MALIGNANCIES IN ADULT AND PAEDIATRIC PATIENTS WITH FBTA05, A TRIFUNCTIONAL ANTIBODY (ANTI-CD3 X ANTI-CD20) AND ALLOGENEIC DONOR LYMPHOCYTE INFUSION
    Buhmann, R.
    Stanglmaier, M.
    Schuster, F.
    Simoes, B.
    Menzel, H.
    Ruf, P.
    Peschel, C.
    Lindhofer, H.
    Borkhardt, A.
    Kolb, H. J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 183 - 183
  • [4] Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies
    Schuster, Friedhelm R.
    Stanglmaier, Michael
    Woessmann, Wilhelm
    Winkler, Beate
    Siepermann, Meinolf
    Meisel, Roland
    Schlegel, Paul G.
    Hess, Juergen
    Lindhofer, Horst
    Borkhardt, Arndt
    Buhmann, Raymund
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 90 - 102
  • [5] Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody
    Buhmann, R.
    Stanglmaier, M.
    Simoes, B.
    Menzel, H.
    Peschel, C.
    Ruf, P.
    Lindhofer, H.
    Kolb, H. -J.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S123 - S123
  • [6] Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
    Stanglmaier, Michael
    Faltin, Margot
    Ruf, Peter
    Bodenhausen, Annette
    Schroeder, Petra
    Lindhofer, Horst
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1181 - 1189
  • [7] Clinical follow-up of paediatric high-risk patients with recurrent CD20 positive B-cell malignancies treated with the trifunctional antibody FBTA05 (anti-CD3 x anti-CD20)
    Schuster, F.
    Stanglmaier, M.
    Woessman, W.
    Winkler, B.
    Ruf, P.
    Schlegel, P.
    Meisel, R.
    Lindhofer, H.
    Borkhardt, A.
    Buhmann, R.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S456 - S456
  • [8] Adoptive immunotherapy of recurrent B-cell malignancies after allogeneic stem cell transplantation with Bi20 (FBTA05) a CD3xCD20 trifunctional antibody and donor lymphocyte transfusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H. -J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S45 - S45
  • [9] IMMUNOTHERAPY WITH THE TRIFUNCTIONAL ANTIBODY FBTA05 IN PEDIATRIC HIGH RISK PATIENTS WITH RECURRENT CD20 POSITIVE B CELL MALIGNANCIES - A CLINICAL FOLLOW UP
    Buhmann, R.
    Schuster, F.
    Stanglmaier, M.
    Woessmann, W.
    Winkler, B.
    Meisel, R.
    Ruf, P.
    Schlegel, P. G.
    Lindhofer, H.
    Reiter, A.
    Borkhardt, A.
    Buhmann, R.
    [J]. HAEMATOLOGICA, 2012, 97 : 479 - 479
  • [10] Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
    Raymund Buhmann
    Stanglmaier Michael
    Hess Juergen
    Lindhofer Horst
    Christian Peschel
    Hans-Jochem Kolb
    [J]. Journal of Translational Medicine, 11
12345